Lack of financial viability has prompted Stanford Hospitals & Clinics (Stanford, CA) to sell the unit of its outreach laboratory that performs routine tests, such as blood chemistry, complete blood count, and urinalysis procedures. The laboratory is not selling the surgical pathology and esoteric testing operations, according to communications director Gary Migdol, who declined to comment on the current sale price.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

April 2008 - Table of Contents

LIR April 2008 (full PDF issue)

Quest Partners With Google to Develop Portable PHR

Debt Load and Economy's Financial Crisis Put Pressure on Bostwick Labs' $100M IPO

Top 10 Lab and Pathology Tests—Surgical Path Leads With $20 Billion in Medicare Dollars

Lab Financial Benchmarks Reveal Psychemedics Tops Productivity Measures

NY Market Shift Helps Boost Bio-Reference, but DSO Benchmarks Cause Concern

Receivables, Bad Debt Could Rise as Economic Downturn Challenges Labs

Sonic Projects 20% to 25% Growth in ’08 as Federated Model and Acquisitions Pose Challenge

Ikonisys Gets CLIA Registration for Niche Reference Lab

Lab Stocks Take a Hit in March; Index Down 12% Over 5 Weeks

Stanford’s Basic Outreach Testing Unit for Sale